"A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation"

If you are interested in learning more about this trial, ResearchMatch can help by contacting the trial team for you. If you’re not a volunteer yet, you’ll first need to join ResearchMatch before we can share your contact information with the research team.